STS-J01 in Japan: In Japan, preliminary results from the investigator-initiated clinical trial (STS-J01) evaluating PEDMARK ® are expected in the fourth quarter of 2025. If the data are positive, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback